370 related articles for article (PubMed ID: 24798149)
1. Urologists' personal feelings on PSA screening and prostate cancer treatment.
Wenzler DL; Rosenberg BH
J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
[TBL] [Abstract][Full Text] [Related]
2. Screening for prostate cancer: a comparison of urologists and primary care physicians.
McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
[TBL] [Abstract][Full Text] [Related]
3. Unravelling the prostate-specific antigen controversy: a West of Scotland perspective.
Zafar N; Miller S; Leburn V; Qureshi KN; Rajan P
Scott Med J; 2014 May; 59(2):126-9. PubMed ID: 24682103
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
5. Practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen levels.
Yoo DS; Woo SH; Cho S; Kang SH; Kim SJ; Park SY; Lee SH; Jeon SH; Park J
Urology; 2014 Jun; 83(6):1339-43. PubMed ID: 24726151
[TBL] [Abstract][Full Text] [Related]
6. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
Kim SP; Gross CP; Nguyen PL; Smaldone MC; Shah ND; Karnes RJ; Thompson RH; Han LC; Yu JB; Trinh QD; Ziegenfuss JY; Sun M; Tilburt JC
Med Care; 2014 Jul; 52(7):579-85. PubMed ID: 24926704
[TBL] [Abstract][Full Text] [Related]
7. Use of prostate-specific antigen in the follow-up of patients with localized prostate cancer: results of a nationwide survey of urologists.
Penson D; Moul J; Gandhi S; Newling D
Urology; 2006 Jul; 68(1):80-4. PubMed ID: 16777198
[TBL] [Abstract][Full Text] [Related]
8. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.
Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Thompson RH; Han LC; Shah ND; Smaldone MC; Gross CP; Frank I; Weight CJ; Beebe TJ; Tilburt JC
BJU Int; 2014 May; 113(5b):E106-11. PubMed ID: 24053213
[TBL] [Abstract][Full Text] [Related]
9. Do Swiss urologists and Swiss internists screen themselves and their relatives for prostate cancer? A questionnaire study.
Scherer TP; Saba K; Wettstein MS; Lucca I; Mortezavi A; Waisbrod S; Aujesky D; Capaul R; Strebel RT
Swiss Med Wkly; 2023 Sep; 153():40115. PubMed ID: 37774392
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.
Fowler FJ; Bin L; Collins MM; Roberts RG; Oesterling JE; Wasson JH; Barry MJ
Am J Med; 1998 Jun; 104(6):526-32. PubMed ID: 9674714
[TBL] [Abstract][Full Text] [Related]
11. Practice trends in the diagnosis and management of prostate cancer in the United States.
Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR
J Urol; 1995 Jul; 154(1):207-8. PubMed ID: 7539862
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
Jønler M; Eddy B; Poulsen J
Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
Hayat Roshanai A; Nordin K; Berglund G
Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
[TBL] [Abstract][Full Text] [Related]
14. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
15. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
[TBL] [Abstract][Full Text] [Related]
16. Attitudes and practices of primary care physicians for prostate cancer screening.
Hoffman RM; Papenfuss MR; Buller DB; Moon TE
Am J Prev Med; 1996; 12(4):277-81. PubMed ID: 8874692
[TBL] [Abstract][Full Text] [Related]
17. Differences between urologists in the United States and Canada in the approach to prostate cancer.
Fleshner N; Rakovitch E; Klotz L
J Urol; 2000 May; 163(5):1461-6. PubMed ID: 10751858
[TBL] [Abstract][Full Text] [Related]
18. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
[TBL] [Abstract][Full Text] [Related]
19. Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practices.
Perez TY; Danzig MR; Ghandour RA; Badani KK; Benson MC; McKiernan JM
Urology; 2015 Jan; 85(1):85-9. PubMed ID: 25440819
[TBL] [Abstract][Full Text] [Related]
20. Urologists' Current Practices in Screening and Treating Men With a Family History of Prostate Cancer.
Rudichuk L; Vogel KJ; Wang CH; Helfand BT; Selkirk CG
Urology; 2017 Jan; 99():180-185. PubMed ID: 27645528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
